<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03616613</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-AAA-2017-42</org_study_id>
    <nct_id>NCT03616613</nct_id>
  </id_info>
  <brief_title>Aortic Abdominal Aneurysm Pilot Screening Programme</brief_title>
  <official_title>Analysis of Aortic Abdominal Aneurysm Prevalence in a Population Pilot Screening Program Based on Primary Care Duplex Ultrasound Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Populational abdominal aortic aneurysm (AAA) pilot screening programme performed by duplex
      ultrasonography in population born in 1952 in health areas depending from Hospital de la
      Santa Creu i Sant Pau in Barcelona. Descriptive data analysis and cost-effectiveness study
      will be performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Populational abdominal aortic aneurysm (AAA) pilot screening programme performed by duplex
      ultrasonography in population born in 1952 in areas depending from Hospital de la Santa Creu
      i Sant Pau in Barcelona. Ultrasonography evaluations will be performed in primary health
      centers by previously trained doctors according to study protocol and AAA management will be
      according to United Kingdom's National Health Service screening model. A descriptive analysis
      will be performed to estimate local population prevalence of AAA in both men and women in
      order to create the basis for a future state AAA screening programme. A cost-effectiveness
      analysis will be performed in order to assess optimal screening strategies in our population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">June 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Abdominal aortic measurement</measure>
    <time_frame>Days (only one day measurement is performed)</time_frame>
    <description>Ultrasound infrarrenal aortic diameter measurement in mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Smoking habits</measure>
    <time_frame>1 day</time_frame>
    <description>Defined by current smoker, former smoker (more than one year without smoking) or non smoker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical intervention if needed</measure>
    <time_frame>1 day</time_frame>
    <description>Registry of kind of intervention and date of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Family AAA history</measure>
    <time_frame>1 day</time_frame>
    <description>First or second degree relatives with AAA, or no family AAA history</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Personal Cardiovascular Risk Factors</measure>
    <time_frame>1 day</time_frame>
    <description>Coronary disease, neurovascular disease, peripheral arterial disease or diabetes mellitus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dislipidaemia</measure>
    <time_frame>1 day</time_frame>
    <description>Altered lipid parameters in blood analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Hypertension</measure>
    <time_frame>1 day</time_frame>
    <description>Arterial hypertension under medical treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>1 day</time_frame>
    <description>measures in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>1 day</time_frame>
    <description>measures in kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal perimeter</measure>
    <time_frame>1 day</time_frame>
    <description>measures in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Goldberg questionnaire</measure>
    <time_frame>1 day</time_frame>
    <description>Complete goldberg anxiety and depression questionnaire. It consists of 12 questions and 5 posible answers for each question, and each answer is rated with 1 to 5 points. Total score above 9 indicates risk of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQOL 5 score</measure>
    <time_frame>1 day</time_frame>
    <description>EuroQOL 5 quality of life evaluation questionnaire. It consistis of 5 questions with 3 posible answers for each question, and a visual analogical scale for self health perception. Each combination of answers indicates a pattern of health status that can be rated.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2194</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <arm_group>
    <arm_group_label>Men</arm_group_label>
    <description>Men born in 1952 in Barcelona in health areas depending from Hospital de la Santa Creu i Sant Pau.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Women</arm_group_label>
    <description>Aleatory sample of women born in 1952 in Barcelona in health areas depending from Hospital de la Santa Creu i Sant Pau.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ABDOMINAL DUPLEX ULTRASONOGRAPHY</intervention_name>
    <description>Abdominal ultrasonography performed by both primary care doctors or vascular surgeons in Hospital de la Santa Creu i Sant Pau area</description>
    <arm_group_label>Men</arm_group_label>
    <arm_group_label>Women</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All men and a random sample of women born in 1952 in Barcelona in the area that depends
        from Hospital de la Santa Creu i Sant Pau.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All men in our area's population census and an aleatory sample of women born in 1952
             living in Hospital de la Santa Creu i Sant Pau area.

        Exclusion Criteria:

          -  Previously detected or operated AAA

          -  Fragile patients not eligible for AAA repair if needed

          -  Dead people when contacted

          -  Eligible people refusing to participate

          -  Eligible people failed to be contacted twice by our department
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 14, 2018</study_first_submitted>
  <study_first_submitted_qc>August 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>August 3, 2018</last_update_submitted>
  <last_update_submitted_qc>August 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

